Golimumab Inhibits Progression of Radiographic Damage in Patients with Psoriatic Arthritis: 52 Week Results From the GO-REVEAL Study.

Arthur Kavanaugh,D. van der Heijde,Dafna D. Gladman,Philip J. Mease,I. B. McInnes,Gerald G. Krueger,W Xu,Mahboob Rahman,Julie Zrubek,A. Baratelle,A. Beutler

Golimumab Inhibits Progression of Radiographic Damage in Patients with Psoriatic Arthritis: 52 Week Results From the GO-REVEAL Study.

2009

Arthur Kavanaugh
D. van der Heijde
Dafna D. Gladman
Philip J. Mease
I. B. McInnes
Gerald G. Krueger
W Xu
Mahboob Rahman
Julie Zrubek
A. Baratelle
A. Beutler

Golimumab Inhibits Progression of Radiographic Damage in Patients with Psoriatic Arthritis: 52 Week Results From the GO-REVEAL Study.: LB5 A. Kavanaugh;D. van der Heijde;D. Gladman;P. Mease;I. McInnes;G. Krueger;W. Xu;M. Rahman;J. Zrubek;A. Baratelle;A. Beutler; Arthritis & Rheumatism

Keywords:

Arthritis
Dermatology
Rheumatism
Golimumab
Radiography
Psoriatic arthritis
in patient
Medicine

Correction
Cite
Save
Machine Reading By IdeaReader

References

Citations